UBL3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.445400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.398000E-01
Normal-vs-Stage2
9.236800E-01
Normal-vs-Stage3
7.665800E-02
Normal-vs-Stage4
2.884600E-01
Stage1-vs-Stage2
3.825700E-02
Stage1-vs-Stage3
2.273900E-02
Stage1-vs-Stage4
8.406000E-01
Stage2-vs-Stage3
1.340560E-03
Stage2-vs-Stage4
1.482010E-01
Stage3-vs-Stage4
6.704500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.544800E-01
Normal-vs-AfricanAmerican
6.489200E-01
Normal-vs-Asian
2.779800E-01
Caucasian-vs-AfricanAmerican
4.037400E-01
Caucasian-vs-Asian
9.118300E-02
AfricanAmerican-vs-Asian
7.998300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.973000E-01
Normal-vs-Female
9.914600E-01
Male-vs-Female
6.680800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.680800E-01
Normal-vs-Age(41-60Yrs)
6.411400E-01
Normal-vs-Age(61-80Yrs)
8.278800E-01
Normal-vs-Age(81-100Yrs)
6.119200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.120000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.478200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.128100E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.780040E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.415600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.703600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.106000E-01
Normal-vs-Daily Drinker
8.883400E-01
Normal-vs-Weekly Drinker
5.627600E-01
Normal-vs-Occasional Drinker
4.605600E-01
Normal-vs-Social Drinker
8.177800E-01
Non Drinker-vs-Daily Drinker
4.115400E-01
Non Drinker-vs-Weekly Drinker
9.237400E-01
Non Drinker-vs-Occasional Drinker
8.995900E-03
Non Drinker-vs-Social Drinker
2.405800E-01
Daily Drinker-vs-Weekly Drinker
5.670400E-01
Daily Drinker-vs-Occasional Drinker
9.748000E-02
Daily Drinker-vs-Social Drinker
4.762200E-01
Weekly Drinker-vs-Occasional Drinker
3.095800E-02
Weekly Drinker-vs-Social Drinker
2.877600E-01
Occasional Drinker-vs-Social Drinker
5.829400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.271560E-01
Normal-vs-Grade 2
1.164070E-02
Normal-vs-Grade 3
2.832200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.646100E-02
Grade 1-vs-Grade 3
1.020230E-01
Grade 1-vs-Grade 4
1.271560E-01
Grade 2-vs-Grade 3
8.566400E-01
Grade 2-vs-Grade 4
1.164070E-02
Grade 3-vs-Grade 4
2.832200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.627400E-01
Normal-vs-NonDiabetic
9.659400E-01
Diabetic-vs-NonDiabetic
1.597610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.053210E-01
Normal-vs-NoPancreatitis
9.652200E-01
Pancreatitis-vs-NoPancreatitis
1.482680E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.760800E-01
Normal-vs-N1
9.824400E-01
N0-vs-N1
5.193600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.998600E-01
Normal-vs-TP53-NonMutant
6.218800E-01
TP53-Mutant-vs-TP53-NonMutant
5.488400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
